Search results
Results from the WOW.Com Content Network
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir Dave Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in ...
This page was last edited on 19 February 2025, at 23:44 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
(Reuters) -Haleon plans to buy back 500 million pounds ($633 million) of its shares this year amid firm demand for its products and progress in reducing debt, sending the British consumer ...
The sale of 630 million shares would be worth about 2.03 billion pounds ($2.58 billion), according to Haleon's Friday closing price. Pfizer, which currently holds a 32% stake in Haleon, said last ...
Sensodyne is a brand of toothpaste that was first sold by Block Drug, a Brooklyn, New York-based company established in 1907 by pharmacist Alexander Block. [1]By 1925, manufacturing dental care products had become the company's focus.
The divestment is expected to dilute Haleon's 2024 net revenue and adjusted operating profit by about 0.5% and about 1%, respectively. The business, which includes the Nicotinell brand of nicotine ...
On July 18, 2022, GSK spun off its consumer healthcare business (including Excedrin) to Haleon. The brand became known for advertisements where it cured especially unpleasant and excruciating headaches (called "Excedrin headaches" in the ads of 1970s, [2] and later called "Excedrin tension headaches"). In 2007, the brand branched out into ...
Macleans Peroxide, circa 1960. Macleans was introduced by New Zealand-born businessman Alex C. Maclean in 1919 during the post-First World War era of consumerism in Great Britain under the family business name of Macleans Limited and Beecham (now GlaxoSmithKline), whose roots originate to the 19th century.